SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: celeryroot.com who wrote (29411)11/18/1999 12:17:00 PM
From: Cheryl Galt  Read Replies (2) | Respond to of 32384
 
Celery, RE the warrants, Another way of saying the same thing:

The offer is for a $1.12 discount on the $7.12 exercise price.

So the exercise price becomes $6.
If all outstanding warrants are exercised, Ligand gets $6 X 3.6M = $21.6 M.

It sounds like a good deal for everyone.

The exercised warrants might hit the market for some quick profit taking, or be held in anticipation of good news from the Targretin trial.

Regards, Cheryl